Company Announcements As part of its 2014–17 medium-term management plan, Takara Bio announced fiscal 2017 sales targets for its Research Reagents business of ¥18,708 million ($184 million) and ¥2,681 million ($26 million) for its Scientific Instruments business to make up 74% and 11% of Bioindustry segment sales, respectively. GTCR completed its acquisition of Cole-Parmer (see […]
Thirteen of the 16 companies in the IBO Laboratory Sales Index reported quarterly earnings before this issue’s publication. Including estimates for companies yet to report, third quarter revenue for the Index grew more than 5% excluding currency, to $6,304 million. Excluding Illumina, Index sales advanced approximately 3% organically. Operating profit improved more than 10% to […]
This month, the Europe University Association’s Public Funding Observatory released a report on public funding of EU institutes of higher education. The report reveals the complex factors underlying this funding. The wide range across the EU in funding often reflected the economic situation of countries over the past six years. Twenty states (or other units) […]
On the verge of a major correction in early October, US equity markets rebounded fervently to end the month in positive territory. The Dow Jones Industrial Average and S&P 500 climbed 2.0% and 2.3%, respectively, in October to close at record highs. The NASDAQ advanced 3.1%. The US markets were encouraged by corporate earnings reports, […]
Jena, Germany 10/1/14—Analytik Jena has sold 50% of its share in AJZ Engineering, its projects company, to ATG Consulting & Controlling. The agreement includes an option to sell the remaining shares by December 31, 2015. “Our aim is to position AJZ Engineering for the future. In line with that, we want to act for the […]
China remains a topic of concern for analytical-instrument and laboratory-product companies as delays in sales this year have slowed growth. New developments in the country could further affect sales growth, which remained stymied in the third quarter, according to PerkinElmer, Thermo Fisher Scientific and Waters. On a macroeconomic level, China’s National Bureau of Statistics reported […]
Santa Clara, CA 10/14/14—Agilent Technologies has announced that it is closing its NMR business because the business has not met growth or profitability objectives. Agilent entered the NMR market in 2010 with the acquisition of Varian (see IBO 7/31/09). “Today’s announcement represents a difficult decision necessary to drive improved profitability,” stated Agilent President, COO and […]
For the second quarter, revenues for IBO’s Lab Equipment/Consumables Index grew 4.1%, 4.0% excluding currency, to $4,278 million. Operating profit for the Index rose 7.6% to $794 million. Based on continuing operations, operating margin gained 50 basis points to 16.5% of sales. Second quarter sales benefited from delayed orders in the first quarter due to […]
Hong Kong 10/9/14; Singapore 10/9/14—Techcomp has agreed to acquire from Bruker the assets related to Bruker’s GC and single-quadrupole GC/MS businesses, including inventories, intellectual property, trademark, licenses and other assets, for $13.5 million. The net book value of the tangible assets is $14 million. Techcomp stated that the acquisition will allow it to expand its […]
Pleasanton, CA 10/9/14—Roche has acquired exclusive rights to target-discovery company AbVitro’s primer-extension–based target-enrichment (PETE) technology and associated patent applications. Financial details were not disclosed. PETE technology will be used to support Roche’s next-generation sequencing (NGS) directly from blood or other biological samples. The technology will be incorporated into the Sequencing Unit’s R&D pipeline to support […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
